Loading
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (4 ops.)
Latest filing published 03 Aug 2018 for AMPHENOL CORP /DE/, €1.2M.
Filing timeline
BuySaleJohn R. Lord
Insider track record
Disclosed buys
3
Disclosed sells
4
Signal history
No signal scores available.
Closed purchases
Market purchases
3
Positive at T+90
100%
Median T+90
+4.0%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +68.8%Entry US$1.53 · Close at T+365 US$2.58
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John R. Lord: trading record in brief
This profile gathers the share dealings of John R. Lord across 2 companies, led by Gerber Scientific Inc and Amphenol Corp /DE/. We count 50 filings; the first trade dates from 30 December 2005 and the latest from 3 August 2018.
The open-market side counts 3 purchases for €244k alongside 4 sales for €5.1M. Sales outweigh purchases by €4.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 32 share grants and 10 option exercises. 2018 to date brings no purchases and 2 sales.
In size, the median ticket on the buying side is €101k.
The record was last updated on 3 August 2018 with an open-market sale (€1.2M) in Amphenol Corp /DE/. The latest purchase dates back some time: it was published 6,577 days ago, on 21 October 2008. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John R. Lord
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
15,013 shares@ US$93.7691.6% of flowClass A Common StockSEC:0001127602-18-024534:0
1,592 shares0Restricted StockSEC:0001127602-18-018249:0
2,000 shares@ US$62.47Class A Common StockSEC:0001127602-18-007663:0
1,921 shares0Restricted StockSEC:0001127602-17-018949:0
2,415 shares0Restricted StockSEC:0001127602-16-053719:0
2,157 shares0Restricted StockSEC:0001127602-15-018379:0
3,333 shares@ US$42.99Class A Common StockSEC:0001127602-14-023926:0
6,667 shares@ US$53.48Class A Common StockSEC:0001127602-14-023926:1
10,000 shares@ US$97.21Class A Common StockSEC:0001127602-14-023926:2
1,310 shares0Restricted StockSEC:0001127602-14-018711:0
1,603 shares0Restricted StockSEC:0001127602-13-018393:0
8,000 shares@ US$16.18Class A Common StockSEC:0001127602-12-033161:0
8,000 shares@ US$20.96Class A Common StockSEC:0001127602-12-033161:1
8,000 shares@ US$26.87Class A Common StockSEC:0001127602-12-033161:2
10,000 shares@ US$34.55Class A Common StockSEC:0001127602-12-033161:3
10,000 shares@ US$45.95Class A Common StockSEC:0001127602-12-033161:4
10,000 shares@ US$32.01Class A Common StockSEC:0001127602-12-033161:5
6,667 shares@ US$42.99Class A Common StockSEC:0001127602-12-033161:6
3,333 shares@ US$53.48Class A Common StockSEC:0001127602-12-033161:7
64,000 shares@ US$61.08Class A Common StockSEC:0001127602-12-033161:8
2,347 shares0Restricted StockSEC:0001127602-12-018248:0
49,996.97 sharesCommon StockSEC:0001123292-11-000689:0
833 shares0Common StockSEC:0001484555-11-000040:0
1,250 shares0Common StockSEC:0001484555-11-000030:0
1,250 shares0Common StockSEC:0001484555-11-000013:0
25 of 41 declarations
